TheraNova

Executive Summary

TheraNova is a San Francisco-based medical device venture studio and incubator that guides concepts from R&D through regulatory clearance and commercialization. With a focus on improving patient outcomes, expanding access, and reducing costs, the company has built a track record since 2006. Its business model de-risks innovation by managing the full development cycle, making it a versatile partner for bringing new technologies to market. While specific projects are not publicly detailed, TheraNova's expertise across multiple therapeutic areas positions it to capitalize on growing demand for cost-effective, minimally invasive solutions.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for a new device70% success
• Q4 2026Strategic partnership with a larger medtech company60% success
• TBDPositive clinical trial results for an existing portfolio product50% success